DS Brar

From SourceWatch
Revision as of 18:38, 19 April 2020 by Mike (talk | contribs) (new)
(diff) ←Older revision | Latest revision (diff) | Newer revision→ (diff)
Jump to navigation Jump to search

In 2011 "Kohlberg Kravis Roberts & Co. (KKR), the global private equity giant with $61.9 billion under management, has appointed former Ranbaxy Laboratories CEO DS Brar as a senior advisor." [1]

Resources and articles

Related Sourcewatch

References

Retrieved from "https://www.sourcewatch.org/index.php?title=DS_Brar&oldid=821855"